Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Singh

Showing results (101-110 of 3,153) with videos related to

Pageof 316
Sort By:
Annals of the Rheumatic Diseases|October 4, 2017
Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and SchechterJasvinder A Singh
Annals of the Rheumatic Diseases|March 9, 2016
Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?Jasvinder A Singh
Arthritis Research & Therapy|January 1, 2014
Veterans Affairs databases are accurate for gout-related health care utilization: a validation studyJasvinder A Singh
Joint Bone Spine|January 27, 2023
Making the current non-surgical treatments for knee osteoarthritis more effective: Solutions from a diverse patient groupJasvinder A Singh
Substance Abuse|July 2, 2021
Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national studyJasvinder A Singh
Journal of Psychiatric Research|June 14, 2021
Letter to the editor: Cocaine use and cocaine use disorder: Revisiting epidemiology and clinical impactJasvinder A Singh
Joint Bone Spine|February 27, 2025
Geography, neighborhoods and mortality in rheumatic diseasesJasvinder A Singh
The Journal of Rheumatology|November 1, 2025
The Reversibility of Urate Tophi With Treat-to-Target in Gout: All Gone. Forever?Jasvinder A Singh
JAMA|July 24, 2019
Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid ArthritisJasvinder A Singh
Joint Bone Spine|February 9, 2021
Time trends in in-hospital mortality reduction in vasculitis vs. non-vasculitis hospitalisations vary by patient sex and ageJasvinder A Singh
Pageof 316

Showing results (101-110 of 3,153) with videos related to

Sort By:
Pageof 316
Annals of the Rheumatic Diseases|October 4, 2017
Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and SchechterJasvinder A Singh
Annals of the Rheumatic Diseases|March 9, 2016
Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?Jasvinder A Singh
Arthritis Research & Therapy|January 1, 2014
Veterans Affairs databases are accurate for gout-related health care utilization: a validation studyJasvinder A Singh
Joint Bone Spine|January 27, 2023
Making the current non-surgical treatments for knee osteoarthritis more effective: Solutions from a diverse patient groupJasvinder A Singh
Substance Abuse|July 2, 2021
Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national studyJasvinder A Singh
Journal of Psychiatric Research|June 14, 2021
Letter to the editor: Cocaine use and cocaine use disorder: Revisiting epidemiology and clinical impactJasvinder A Singh
Joint Bone Spine|February 27, 2025
Geography, neighborhoods and mortality in rheumatic diseasesJasvinder A Singh
The Journal of Rheumatology|November 1, 2025
The Reversibility of Urate Tophi With Treat-to-Target in Gout: All Gone. Forever?Jasvinder A Singh
JAMA|July 24, 2019
Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid ArthritisJasvinder A Singh
Joint Bone Spine|February 9, 2021
Time trends in in-hospital mortality reduction in vasculitis vs. non-vasculitis hospitalisations vary by patient sex and ageJasvinder A Singh
Pageof 316